Created at	Source	Raw Value	Validated value
May 21, 2022, 9:30 a.m.	usa	Immune response to mRNA-1273.214, given as a fourth and fifth dose to participants who previously received mRNA primary series vaccination and one booster dose (third dose).;Reactogenicity of the study vaccines after each dose;Safety of the study vaccines after each dose	Immune response to mRNA-1273.214, given as a fourth and fifth dose to participants who previously received mRNA primary series vaccination and one booster dose (third dose).;Reactogenicity of the study vaccines after each dose;Safety of the study vaccines after each dose